0.7500
-0.0257
(-3.31%)
At close: April 17 at 4:00:00 PM EDT
0.7929
+0.04
+(5.72%)
After hours: April 17 at 5:18:31 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
Total Assets
2,863
5,256
9,333
Total Liabilities Net Minority Interest
6,852
17,312
16,412
Total Equity Gross Minority Interest
-3,989
-12,056
-7,079
Total Capitalization
-1,028
-15,476
-10,665
Common Stock Equity
-3,989
-15,476
-10,665
Capital Lease Obligations
526
171
271
Net Tangible Assets
-3,989
-15,476
-10,665
Working Capital
-1,273
2,783
7,229
Invested Capital
-24
-15,476
-10,665
Tangible Book Value
-3,989
-15,476
-10,665
Total Debt
4,491
171
271
Net Debt
2,778
--
--
Share Issued
1,849.1320
905.7380
905.7380
Ordinary Shares Number
1,849.1320
905.7380
905.7380
12/31/2022 - 4/7/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TVGN Tevogen Bio Holdings Inc.
0.9796
-3.96%
REVB Revelation Biosciences, Inc.
3.0800
+2.67%
BDRX Biodexa Pharmaceuticals Plc
1.4300
-0.69%
IBO Impact BioMedical Inc.
0.4026
-7.87%
RNAZ TransCode Therapeutics, Inc.
0.2725
-23.58%
OSRH OSR Holdings, Inc.
1.3300
-2.21%
PALI Palisade Bio, Inc.
0.7199
+2.80%
DWTX Dogwood Therapeutics, Inc.
4.2700
+14.48%
SPRC SciSparc Ltd.
0.2826
+4.24%
ZVSA ZyVersa Therapeutics, Inc.
0.6991
-1.89%